Randy F Sweis

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Current oncology reports

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Kunal B Desai, Anthony V Serritella, Walter M Stadler, Peter H O'Donnell, Randy F Sweis, Russell Zelig Szmulewitz
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Kunal B Desai, Anthony V Serritella, Walter M Stadler, Peter H O'Donnell, Randy F Sweis, Russell Zelig Szmulewitz
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Kunal B Desai, Anthony V Serritella, Walter M Stadler, Peter H O'Donnell, Randy F Sweis, Russell Zelig Szmulewitz
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Kunal B Desai, Anthony V Serritella, Walter M Stadler, Peter H O'Donnell, Randy F Sweis, Russell Zelig Szmulewitz
A phase I trial of enzalutamide plus selective glucocorticoid receptor modulator relacorilant in patients with metastatic castration resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yixuan Wang, Daniel R Bergman, Erica Trujillo, Anthony A Fernald, Lie Li, Alexander T Pearson, Randy F Sweis, Trachette L Jackson
Agent-Based Modeling of Virtual Tumors Reveals the Critical Influence of Microenvironmental Complexity on Immunotherapy Efficacy. Cancers 16 (17) (2024)
Kunal B Desai, Anthony V Serritella, Walter M Stadler, Peter H O'Donnell, Randy F Sweis, Russell Zelig Szmulewitz
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Kunal B Desai, Anthony V Serritella, Walter M Stadler, Peter H O'Donnell, Randy F Sweis, Russell Zelig Szmulewitz
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Jacobi B Hines, Alec J Kacew, Randy F Sweis
The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy. Current oncology reports 25 (3) (2023)
Jacobi B Hines, Alec J Kacew, Randy F Sweis
The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy. Current oncology reports (2023)
Jacobi B Hines, Alec J Kacew, Randy F Sweis
The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy. Current oncology reports 25 (3) (2023)
Maria Karasarides, Alexandria P Cogdill, Paul B Robbins, Michaela Bowden, Elizabeth M Burton, Lisa H Butterfield, Alessandra Cesano, Christian Hammer, Cara L Haymaker, Christine E Horak, Heather M McGee, Anne Monette, Nils-Petter Rudqvist, Christine N Spencer, Randy F Sweis, Benjamin G Vincent, Erik Wennerberg, Jianda Yuan, Roberta Zappasodi, Vanessa M Hubbard Lucey, Daniel K Wells, Theresa LaVallee
Hallmarks of Resistance to Immune-Checkpoint Inhibitors. Cancer immunology research 10 (4) (2022)
Funda Meric-Bernstam, Randy F Sweis, Stefan Kasper, Omid Hamid, Shailender Bhatia, Reinhard Dummer, Agostina Stradella, Georgina V Long, Anna Spreafico, Toshio Shimizu, Neeltje Steeghs, Jason John Luke, Sarah M McWhirter, Thomas Müller, Nitya Nair, Nancy Lewis, Xinhui Chen, Andrew Bean, Lisa M Kattenhorn, Marc R Pelletier, Shahneen Sandhu
Combination of the STING Agonist MIW815 and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-label, Multicenter, Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Valentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau, Alexander Spira, Funda Meric-Bernstam, Nataliya Uboha, Rachel E Sanborn, Randy F Sweis, Patricia LoRusso, Misako Nagasaka, Javier García Corbacho, Shadia Jalal, James J Harding, Stella K Kim, Iris H C Miedema, Danielle J Vugts, Marc C Huisman, Gerben J C Zwezerijnen, Guus A M S van Dongen, Catharina Willemien Menke-van der Houven van Oordt, Song Wang, Tam Dang, Ivan A Zein, Olga Vasiljeva, Susan K Lyman, Virginia Paton, Alison Hannah, Joyce F Liu
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Funda Meric-Bernstam, Randy F Sweis, F Stephen Hodi, Wells A Messersmith, Robert H I Andtbacka, Matthew Ingham, Nancy Lewis, Xinhui Chen, Marc Pelletier, Xueying Chen, Jincheng Wu, Sarah M McWhirter, Thomas Müller, Nitya Nair, Jason John Luke
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients With Advanced/Metastatic Solid Tumors or Lymphomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Jasmin Quandt, Stephen Arnovitz, Leila Haghi, Janine Woehlk, Azam Mohsin, Michael Okoreeh, Priya S Mathur, Akinola Olumide Emmanuel, Abu Osman, Manisha Krishnan, Samuel B Morin, Alexander T Pearson, Randy F Sweis, Joel Pekow, Christopher R Weber, Khashayarsha Khazaie, Fotini Gounari
Wnt-β-catenin activation epigenetically reprograms Treg cells in inflammatory bowel disease and dysplastic progression. Nature immunology 22 (4) (2021)
Jonathan A Trujillo, Randy F Sweis, Riyue Bao, Jason J Luke
T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer immunology research 6 (9) (2019)
Jason J Luke, Riyue Bao, Randy F Sweis, Stefani Spranger, Thomas F Gajewski
WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (10) (2019)